These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23075248)

  • 41. Added diagnostic value of CSF biomarkers in differential dementia diagnosis.
    Le Bastard N; Martin JJ; Vanmechelen E; Vanderstichele H; De Deyn PP; Engelborghs S
    Neurobiol Aging; 2010 Nov; 31(11):1867-76. PubMed ID: 19150153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
    Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current state and future directions of neurochemical biomarkers for Alzheimer's disease.
    de Jong D; Kremer BP; Olde Rikkert MG; Verbeek MM
    Clin Chem Lab Med; 2007; 45(11):1421-34. PubMed ID: 17970699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interpretation of Biomarker Data in Diagnosis of Primary Dementias.
    Salardini A
    Semin Neurol; 2019 Apr; 39(2):200-212. PubMed ID: 30925613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurochemical biomarkers in Alzheimer's disease and related disorders.
    Bibl M; Esselmann H; Wiltfang J
    Ther Adv Neurol Disord; 2012 Nov; 5(6):335-48. PubMed ID: 23139704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular biology of Alzheimer's dementia and its clinical relevance to early diagnosis and new therapeutic strategies.
    Wiltfang J; Esselmann H; Maler JM; Bleich S; Hüther G; Kornhuber J
    Gerontology; 2001; 47(2):65-71. PubMed ID: 11287729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer's Disease?
    Bolognesi ML; Gandini A; Prati F; Uliassi E
    J Med Chem; 2016 Sep; 59(17):7759-70. PubMed ID: 27124551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The neurologist role in diagnostics and therapy of the Alzheimer's disease].
    Loncarević N; Mehmedika-Sulić E; Alajbegović A; Kucukalić A
    Med Arh; 2005; 59(2):106-9. PubMed ID: 15875473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dementia diagnostics 2.0--transfer from research studies into routine clinical practice.
    Otto M
    Clin Chem; 2010 Feb; 56(2):152-3. PubMed ID: 19884484
    [No Abstract]   [Full Text] [Related]  

  • 50. Bruno Dubois: transforming the diagnosis of Alzheimer's disease.
    Holmes D
    Lancet Neurol; 2014 Jun; 13(6):541. PubMed ID: 24849858
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical approach and pathological cascabe of dementia].
    Shoji M
    Rinsho Shinkeigaku; 2008 Jul; 48(7):467-75. PubMed ID: 18717179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Algorithmic identification of persons with dementia for research recruitment: ethical considerations.
    London AJ; Karlawish J; Largent EA; Hey SP; McCarthy EP
    Inform Health Soc Care; 2024 Jan; 49(1):28-41. PubMed ID: 38196387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A unified model of dementias and age-related neurodegeneration.
    Fossel M
    Alzheimers Dement; 2020 Feb; 16(2):365-383. PubMed ID: 31943780
    [No Abstract]   [Full Text] [Related]  

  • 54. Disease-related data patterns in cerebrospinal fluid diagnostics: medical quality versus analytical quantity.
    Reiber H
    Front Mol Biosci; 2024; 11():1348091. PubMed ID: 39324113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Eye on Clinical Translation-Considerations for Research Into Ocular Biomarkers of Alzheimer Disease and Related Dementias.
    Barrett-Young A
    JAMA Ophthalmol; 2023 Jan; 141(1):91-92. PubMed ID: 36394847
    [No Abstract]   [Full Text] [Related]  

  • 56. Solution to the neurochemical challenge.
    Heien ML; Sweedler JV
    Anal Bioanal Chem; 2007 May; 388(1):3. PubMed ID: 17340082
    [No Abstract]   [Full Text] [Related]  

  • 57. Editorial: Methods and applications in Alzheimer's disease and related dementias.
    Yogi A; Grosso CA
    Front Aging Neurosci; 2022; 14():1083257. PubMed ID: 36523956
    [No Abstract]   [Full Text] [Related]  

  • 58. Oxford Brain Diagnostics: turning MRI into a diagnosis tool for dementia.
    Makin S
    Nature; 2020 Jun; ():. PubMed ID: 32606408
    [No Abstract]   [Full Text] [Related]  

  • 59. A Neurochemical Basis for Phenotypic Differentiation in Alzheimer's Disease? Turing's Morphogens Revisited.
    Whittaker HT; Warren JD
    Front Aging Neurosci; 2017; 9():76. PubMed ID: 28424609
    [No Abstract]   [Full Text] [Related]  

  • 60. Late diagnostics of Alzheimer's disease and other dementias, retrospective research in Vilnius (Lithuania):
    Vaikutytė R; Lekečinskaitė L
    Porto Biomed J; 2017; 2(5):235-236. PubMed ID: 32258751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.